Bliss GVS Pharma
BLISSGVS · Pharma > Pharmaceuticals & Drugs · Chairman: S R Vaidya · MD: Gagan Harsh Sharma · Listing date: July 26, 2010 · Employees: 683 · Mumbai · http://www.blissgvs.com

Stock Price vs Company Growth
1d
0.4%
1w
0.7%
1m
8.8%
3m
7.3%
6m
23.1%
1y
4.5%
5y
0.0%
10y
0.3%
all
10.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 167 0.4%
118
178
Company Overview

Sales
860 Cr
Growth: 6.3%
Profit after Tax
110 Cr
Growth: 2.8%
Small Cap
1,770 Cr
P/E: 16.2x
Industry P/E: 33.3x
Fundamentals

Sales (Cr) ₹ 860
Growth 6.3%
EBITDA 14.4%
P/S 2.1x
Dividend 0.4%
P/E 16.2x
Book Value ₹ 106
PEG Ratio 2.5x
ROE 10.2%
P/B 1.6x
Shareholding Pattern

Institutions
Arian Investment Ltd
9.7 %
Life Insurance Corporation Of India
6.68 %
Polus Global Fund
4.62 %
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
2.9 %
Aspire Emerging Fund
2.46 %
Promoters
Narsimha Shibroor Kamath
33.24 %
Others
Gulbarga Trading And Investment Pvt. Ltd.
5.67 %
Arjun Gautam Ashra
4.89 %
Gautam Rasiklal Ashra
2.82 %
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs
2.2 %
Llp
0.05 %
Increase    Decrease    No change
Company Profile Detailed

It is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception.
Investors (65)
Followers (10)